Skip to main navigation
Instil Bio logo
  • Home
  • News & Events
    • News Releases
    • Events
  • Stock Information
    • Stock Quote & Chart
    • Historical Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • Corporate Governance
    • Documents & Charters
    • Management Team
    • Board of Directors
    • Committee Composition
  • Financials & Filings
    • SEC Filings
  • IR Resources
    • FAQs
    • Email Alerts
    • Contact IR

News Releases

November 15, 2021
Instil Bio Reports Third Quarter 2021 Financial Results and Provides Corporate Update
November 15, 2021
Instil Bio Announces Poster Presentations at the 2021 Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 8, 2021
Instil Bio to Present at Upcoming Investor Conferences in November
September 16, 2021
Instil Bio Presents Subset Analysis of Patients with Checkpoint-Refractory Advanced Melanoma from Compassionate Use Study at 2021 ESMO Congress
September 13, 2021
Instil Bio Receives IND Clearance to Initiate a Phase 2 Clinical Trial for Patients with Advanced Melanoma
September 2, 2021
Instil Bio to Present at Upcoming Investor Conferences in September
August 12, 2021
Instil Bio Reports Second Quarter 2021 Financial Results and Provides Corporate Update
June 1, 2021
Instil Bio to Present at the Jefferies Virtual Healthcare Conference
May 13, 2021
Instil Bio Reports First Quarter 2021 Financial Results and Provides Corporate Update
April 27, 2021
Instil Bio Receives Orphan Drug Designation for ITIL-168 in Melanoma

Pagination

  • Current page 1
  • Page 2
  • Next page next ›
  • Last page last »

Investor Tools

Instil Bio Instil Bio

Footer Menu

  • About
  • Careers
  • Pipeline
  • Contact Us
  • Publications

Site Social Media Links

  • LinkedIn LinkedIn
  • Twitter Twitter
© 2022 Instil Bio. All Rights Reserved
Privacy Policy Terms of Service Agency Policy